Rapid Antigen vs PCR: Why the Same Person Can Test Both Ways

A person really can be positive on a PCR test and negative on a rapid antigen test at the same moment, and in most cases neither result is wrong. The two tests answer different questions: PCR amplifies the virus's genetic material through repeated cycles, so it detects a few copies of viral RNA and turns positive early, often staying positive for weeks after recovery. A rapid antigen test looks for viral protein and needs far more of it on the swab to produce a visible line, so it flags the narrower window when you carry enough virus to be infectious. A discordant result usually reflects where you sit on the rise and fall of viral load rather than a laboratory error.

What each test is built to detect

Molecular tests, of which PCR is the best known, are nucleic acid amplification tests. They copy any viral RNA present through successive cycles until even a tiny starting amount becomes detectable. That sensitivity is the point of the method, and it has a consequence people rarely hear about: PCR can remain positive for a week or more after live virus is gone, because it is detecting genetic fragments rather than intact, infectious particles. The number of amplification cycles needed to cross the detection threshold, the cycle threshold or Ct value, is an inverse marker of how much virus was on the swab, though it is not standardized enough to read as a precise viral load.

A rapid antigen test works differently. It uses antibodies fixed to a strip to capture a viral protein, usually the nucleocapsid, and produces a line only when enough of that protein is present. There is no amplification step, so the test has a much higher limit of detection. That is a design feature, not a defect. Because antigen levels roughly track the amount of replicating virus, a positive antigen result correlates more closely with culturable, potentially transmissible virus than a positive PCR does.

Sensitivity rises and falls with viral load

The clearest way to see this is to compare an antigen test against two different reference standards. In a CDC Respiratory Virus Transmission Network study published in MMWR on April 25, 2024, investigators followed 236 people with confirmed SARS-CoV-2 infection and tested them repeatedly. Rapid antigen sensitivity was 47 percent when measured against RT-PCR but 80 percent when measured against viral culture. In other words, antigen tests missed roughly half of all PCR-detectable infection yet caught about four in five of the samples that actually grew live virus. Sensitivity climbed with viral activity: it peaked around the time of fever (about 77 percent versus PCR and 94 percent versus culture) and fell sharply when people were asymptomatic (about 18 percent versus PCR).

Independent evidence points the same direction. A Cochrane systematic review by Dinnes and colleagues, updated in 2022, pooled dozens of evaluations and found average antigen sensitivity of 73 percent in symptomatic people versus 54.7 percent in asymptomatic people, and 80.9 percent within the first week of symptoms. High viral load, which usually means symptomatic and early, is where antigen tests do their best work.

Why serial antigen testing is built to track infectiousness

A single antigen test is a snapshot of one moment on a moving curve. Viral load climbs over the first days of infection, so a swab taken before you cross the antigen threshold can read negative even though the same infection will be obvious two days later. That is the reasoning behind serial testing.

The FDA-supported Test Us at Home study, published by Soni and colleagues in Annals of Internal Medicine in 2023 and summarized by the NIH's imaging and bioengineering institute, quantified the gain. Among symptomatic participants, sensitivity rose from about 83 percent on the first test to 93 percent when a second test was added 48 hours later. Among asymptomatic participants the jump was larger: roughly 39 percent on a single test, 63 percent after a second, and 79 percent after a third at 48-hour intervals. Those findings underpin current FDA guidance that a negative at-home antigen test be repeated, at least twice if you have symptoms and at least three times if you do not, spaced about 48 hours apart.

Read that way, serial antigen testing is not a workaround for a weak test. It is the intended use. Each repeat resamples whether you are currently shedding enough virus to matter, which is the question an antigen test is designed to answer.

Reading a discordant result

Timing and context turn a confusing pair of results into a coherent story. An antigen-negative, PCR-positive result early in a symptomatic illness often means you tested before your viral load peaked, and repeating the antigen test in 48 hours is the logical next step. The same combination late in an illness, or weeks after a known infection, more likely reflects residual RNA that PCR still detects after you have stopped being infectious. The reverse pattern, antigen-positive and PCR-negative, is uncommon; antigen tests are highly specific, so a positive is rarely a false alarm, but sampling and timing differences between two swabs can explain it.

One practical caveat carries real weight. The MMWR authors noted that people eligible for antiviral treatment should seek a more sensitive molecular test, because those medicines work best when started early and an antigen test can be negative during exactly that window. This article is educational and is not a substitute for individualized medical advice.

The takeaway

Antigen and PCR tests are not competing measures of the same thing. PCR answers whether viral genetic material is present, an extremely sensitive question that can stay positive long after you recover. An antigen test answers whether you are carrying a lot of virus right now, which is closer to the question of whether you can infect someone else. Understanding that difference explains why the same person can test both ways on the same day, and why testing more than once is often the informative move.